1. Zhang L. A common mechanism links Epstein‐Barr virus infections and autoimmune diseases. J Med Virol. 2023;95(1):e28363. [DOI:10.1002/jmv.28363] [PMID]

2. Zamani B, Shayestehpour M, Esfahanian F, Akbari H. The study of factors associated with pregnancy outcomes in patients with systemic lupus erythematosus. BMC Res Notes. 2020;13(1):1-6. [DOI:10.1186/s13104-020-05039-9] [PMID] []

3. Jiao H, Acar G, Robinson GA, Ciurtin C, Jury EC, Kalea AZ. Diet and Systemic Lupus Erythematosus (SLE): From Supplementation to Intervention. Int J Environ Res Public Health. 2022;19(19):11895. [DOI:10.3390/ijerph191911895] [PMID] []

4. Liu JL, Woo JM, Parks CG, Costenbader KH, Jacobsen S, Bernatsky S. Systemic Lupus Erythematosus Risk: The Role of Environmental Factors. Rheum Dis Clin. 2022;48(4):827-43. [DOI:10.1016/j.rdc.2022.06.005] [PMID]

5. Zamani B, Moeini Taba S-M, Shayestehpour M. Systemic lupus erythematosus manifestation following COVID-19: a case report. J Med Case Rep. 2021;15(1):1-4. [DOI:10.1186/s13256-020-02582-8] [PMID] []

6. Shayestehpour M, Zamani B. Systemic lupus erythematosus and varicella‐like rash following COVID‐19 in a previously healthy patient. J Med Virol. 2021;93(5):2599. [DOI:10.1002/jmv.26838] [PMID] []

7. Jog NR, James JA. Epstein Barr virus and autoimmune responses in systemic lupus erythematosus. Front Immunol. 2021;11:623944. [DOI:10.3389/fimmu.2020.623944] [PMID] []

8. Jia X, Gong L, Huang G, Zhang W. Review of correlation between human parvovirus B19 and autoimmune disease etiology. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020;36(1):75-80.

9. Choo HMC, Cher WQ, Kwan YH, Fong WWS. Risk factors for cytomegalovirus disease in systemic lupus erythematosus (SLE): a systematic review. Adv Rheumatol. 2019;59. [DOI:10.1186/s42358-019-0055-y] [PMID]

10. Talotta R, Atzeni F, Laska MJ. Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets? Autoimmunity. 2020;53(4):177-91. [DOI:10.1080/08916934.2020.1755962] [PMID]

11. Sagir A, Kirschberg O, Heintges T, Erhardt A, Häussinger D. SEN virus infection. Rev Med Virol. 2004;14(3):141-8. [DOI:10.1002/rmv.421] [PMID]

12. Sharifi Z, Mahmoudian SM, Talebian A. The prevalence of SEN virus infection in blood donors in Iran. Arch Iran Med. 2008 Jul;11(4):423-6.

13. Bahabadinejad M, Bouzari M, Talebi A. Frequency of SEN Virus in Cervicitis and Cervical Cancers in Isfahan. JIMS. 2011;29(147):912.

14. Pirouzi A, Bahmani M, Feizabadi MM, Afkari R. Molecular characterization of Torque teno virus and SEN virus co-infection with HIV in patients from Southern Iran. Rev Soc Bras Med Trop. 2014;47:275-9. [DOI:10.1590/0037-8682-0073-2014] [PMID]

15. Karimi-Rastehkenari A, Bouzari M. High frequency of SEN virus infection in thalassemic patients and healthy blood donors in Iran. Virol J. 2010;7:1-7. [DOI:10.1186/1743-422X-7-1] [PMID] []

16. Costa MRd, Costa IPd, Devalle S, Castro ARCMd, Freitas SZ. Prevalence and genetic diversity of torque teno virus in patients with systemic lupus erythematosus in a reference service in Mato Grosso do Sul. Rev Bras Reumatol. 2012;52:49-54. [DOI:10.1590/S0482-50042012000100006]

17. Gergely Jr P, Pullmann R, Stancato C, Otvos Jr L, Koncz A, Blazsek A, et al. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clin Immunol. 2005;116(2):124-34. [DOI:10.1016/j.clim.2005.04.002] [PMID]

18. Shibata M, Wang RY-H, Yoshiba M, Shih JW-K, Alter HJ, Mitamura K. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. J Infect Dis. 2001;184(4):400-4. [DOI:10.1086/322050] [PMID]

19. Pirovano S, Sottini A, Bianchi V. Incidence of the SENV-A subtype in different cohorts of patients .Antivir Ther. 2000;5.